McKesson just locked CVS in through 2032

Same old friends, longer contract

McKesson says it has an agreement in principle to extend its long-running partnership with CVS Health through June 2032. In plain English: the medicines keep moving, the relationship stays intact, and both sides get to avoid the corporate version of a messy breakup.

Why investors should care

This isn’t some flashy moonshot news, but it is the kind of deal that keeps the engine humming. McKesson’s distribution business depends on large, sticky customer relationships, and CVS is exactly the sort of customer you’d rather keep than chase.

• The agreement covers mail order and specialty pharmacies
• It also includes retail pharmacies and distribution centers
• The extension runs all the way to June 2032

Big picture

For McKesson, this is basically a “don’t touch the thermostat” update: not thrilling, but very much welcome. Long-term visibility in a capital-light, high-volume business is the kind of thing investors tend to reward with a quieter heartbeat.